ArticleBMC health services research2022

Cost of illness of HER2-positive and metastatic and recurrent HER2-positive breast cancer - a Danish register-based study from 2005 to 2016.

M Spanggaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.